FACBC (fluciclovine F-18)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FACBC (fluciclovine F-18), covering 2025-12-18 to 2025-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study [Phase 2]